Mississauga, Canada

Werner Oberegger

This inventor holds 16 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent, primarily in Pharmaceutical Formulations. Top assignees: Biovail Laboratories International S.r.l., Biovail Laboratories, Inc., Valeant International Bermuda. Active years: 2007-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Werner Oberegger. Retrieved from https://idiyas.com/inventor/werner-oberegger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.7

ph-index = 6

Forward Citations = 737(Granted Patents)


Location History:

  • Burlington, CA (2010)
  • Mississauga, CA (2007 - 2016)

Company Filing History:


Years Active: 2007-2016

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Bupropion Salt
Modified Release
Therapeutic Applications
Pharmaceutical Formulations
Drug Delivery
Controlled Release
Tablet Formulations
Hydrobromide
Hydrochloride
Formulation Chemistry
Pharmacokinetics
Dosage Forms
16 patents (USPTO):Explore Patents

Title: Werner Oberegger: Innovator in Pharmaceutical Formulations

Introduction: Werner Oberegger, based in Mississauga, Canada, is a distinguished inventor known for his contributions to the field of pharmaceutical innovations. With a remarkable portfolio of 16 patents, Oberegger has made significant strides in the development of modified-release formulations, particularly focusing on bupropion salts.

Latest Patents: Among his latest inventions is a patent concerning modified release formulations of a bupropion salt. This invention relates to pharmaceutical compositions that comprise a bupropion salt, specifically highlighting modified-release tablets that contain an effective amount of bupropion hydrobromide. The formulations aim to provide enhanced therapeutic efficacy in treating various conditions.

Career Highlights: Werner Oberegger has demonstrated an unwavering commitment to advancing pharmaceutical science throughout his career. He has been instrumental in the development of innovative drug formulations that enhance patient outcomes. His work showcases a blend of scientific expertise and a keen understanding of market needs in the pharmaceutical industry.

Collaborations: Throughout his career, Oberegger collaborated with esteemed professionals, including Paul Maes and Mohammad Ashty Saleh. These collaborations have significantly enriched his work and contributed to the successful development of his patented inventions. Additionally, he has worked with well-respected companies in the industry, such as Biovail Laboratories International S.r.l. and Valeant International Bermuda.

Conclusion: Werner Oberegger's contributions to pharmaceutical innovations reflect a deep understanding of formulation science and a drive to improve patient care. His portfolio of patents stands as a testament to his creativity and dedication as an inventor. As the pharmaceutical landscape continues to evolve, Oberegger's work will undoubtedly inspire future innovations in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…